Skip Navigation

Alzheimer’s disease drugs linked to reduced risk of heart attacks

5 June 2013

Drugs that are used for treating Alzheimer’s disease in its early stages are linked to a reduced risk of heart attacks and death, according to a large study of over 7,000 people with Alzheimer’s disease in Sweden.

The research, which is published online in the European Heart Journal, looked at cholinesterase inhibitors (ChEIs), such as donepezil, rivastigmine and galantamine, which are used for treating mild to moderate Alzheimer’s disease. Side-effects of ChEIs include a beneficial effect on the vagus nerve, which controls the rate at which the heart beats, and some experimental studies have suggested that ChEIs could also have anti-inflammatory properties.

Read the press release.
Read the full paper.